Can B Corp CANB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CANB is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.03
- Day Range
- $0.03–0.03
- 52-Week Range
- $0.01–0.89
- Bid/Ask
- $0.03 / $0.03
- Market Cap
- $1.70 Mil
- Volume/Avg
- 49,545 / 376,198
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.20
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Can B Corp is engaged in the business of promoting health and wellness through its development, manufacture and sale of products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. The company focuses on developing a line of proprietary products in the Hemp Industry.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 12
- Website
- https://www.canbiola.com
Valuation
|
Metric
|
CANB
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.20 |
Price/Cash Flow | — |
Price/Earnings
CANB
Financial Strength
|
Metric
|
CANB
|
|---|---|
Quick Ratio | 0.34 |
Current Ratio | 0.48 |
Interest Coverage | −2.87 |
Quick Ratio
CANB
Profitability
|
Metric
|
CANB
|
|---|---|
Return on Assets (Normalized) | −53.60% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −54.00% |
Return on Assets
CANB
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Sgrhsljh | Wycyh | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Rftjhxzyfn | Mtkbz | $68.1 Bil | |
HLN
| Haleon PLC ADR | Fdpzrsqc | Hfhh | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Pbrgtdpj | Xggw | $14.3 Bil | |
VTRS
| Viatris Inc | Sfxndrh | Yfdhs | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Xbtjkwvz | Bftb | $11.9 Bil | |
CTLT
| Catalent Inc | Ylclzmcsv | Bhvkkn | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Bqdzlztl | Thkh | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Wgdfnpp | Trl | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ghvwjwmml | Skgnyj | $3.4 Bil |